Author Interview: Professor Helena Marzo-Ortega, March 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Helena Marzo-Ortega an academic clinician and the Clinical Lead of the multi-award winning Leeds Specialist Spondyloar...
9 Apr 37min
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patient...
26 Mar 10min
Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers
Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer symptom duration on the e...
19 Mar 33min
Author Interview: Doctor Carlo Tur, February 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University, Erlangen-Nurnbe...
12 Mar 29min
Author Interview - Professor Andrew Cope, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they discuss his recent pape...
5 Mar 24min
Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Taylor et al. where authors report the...
27 Feb 8min
Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘classification of patients into distinct PsA phenotype...
13 Feb 20min
Author Interview: Professor Matthew Brown, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as they discuss his recent paper ‘Low uveitis rates i...
3 Feb 18min
